Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation
Gespeichert in:
| Veröffentlicht in: | Clinical pharmacology and therapeutics 2007-02, Vol.81 (2), p.153-155 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 155 |
|---|---|
| container_issue | 2 |
| container_start_page | 153 |
| container_title | Clinical pharmacology and therapeutics |
| container_volume | 81 |
| creator | Wilson, C Schulz, S Waldman, S A |
| description | |
| doi_str_mv | 10.1038/sj.clpt.6100088 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68955424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68955424</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3738-52c0dacfc3fadd61e46fa01d6cf639608838352150d7b190d3bcbb8a5ecaee053</originalsourceid><addsrcrecordid>eNqFkE1P3DAQhq2qqCyUc2-VL-VEFjtee-3e2uVTWkRVLWfLsSeVFyde4gQEvx7TDXDkNJrRM2O_D0LfKJlSwuRxWk9t2PRTQQkhUn5CE8pZWQjO-Gc0yTNVqJKJXbSX0jq3MyXlF7RL5yVXiqkJuv3tY2O6W-jwCdxDiJsG2v4IL2LTQGe9Cf7J9D62R9i0Dv-Ff0P43__El63z994NbwiONb4C561vAS9j6rFv8aozbdqufEU7tQkJDsa6j27OTleLi2J5fX65-LUsLJszWfDSEmdsbVltnBMUZqI2hDpha8GUyDGZZLyknLh5RRVxrLJVJQ0HawAIZ_vocHt308W7AVKvG58shGBaiEPSQirOZ-Usg8db0HYxpQ5qvel8tvGoKdEvfnVa6xe_evSbN76Pp4eqAffOj0Iz8GMETLIm1Dm99emdkzwHECJz8y334AM8fvSuXvxZvX7hGY6zmDM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68955424</pqid></control><display><type>article</type><title>Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Wilson, C ; Schulz, S ; Waldman, S A</creator><creatorcontrib>Wilson, C ; Schulz, S ; Waldman, S A</creatorcontrib><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1038/sj.clpt.6100088</identifier><identifier>PMID: 17259939</identifier><identifier>CODEN: CLPTAT</identifier><language>eng</language><publisher>New York, NY: Nature Publishing</publisher><subject>Biological and medical sciences ; Biomarkers ; Drug Approval ; Humans ; Marketing - methods ; Medical sciences ; National Institutes of Health (U.S.) ; Pharmacology. Drug treatments ; Technology, Pharmaceutical - methods ; United States ; United States Food and Drug Administration</subject><ispartof>Clinical pharmacology and therapeutics, 2007-02, Vol.81 (2), p.153-155</ispartof><rights>2007 American Society for Clinical Pharmacology and Therapeutics</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3738-52c0dacfc3fadd61e46fa01d6cf639608838352150d7b190d3bcbb8a5ecaee053</citedby><cites>FETCH-LOGICAL-c3738-52c0dacfc3fadd61e46fa01d6cf639608838352150d7b190d3bcbb8a5ecaee053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1038%2Fsj.clpt.6100088$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1038%2Fsj.clpt.6100088$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18560866$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17259939$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilson, C</creatorcontrib><creatorcontrib>Schulz, S</creatorcontrib><creatorcontrib>Waldman, S A</creatorcontrib><title>Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Drug Approval</subject><subject>Humans</subject><subject>Marketing - methods</subject><subject>Medical sciences</subject><subject>National Institutes of Health (U.S.)</subject><subject>Pharmacology. Drug treatments</subject><subject>Technology, Pharmaceutical - methods</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1P3DAQhq2qqCyUc2-VL-VEFjtee-3e2uVTWkRVLWfLsSeVFyde4gQEvx7TDXDkNJrRM2O_D0LfKJlSwuRxWk9t2PRTQQkhUn5CE8pZWQjO-Gc0yTNVqJKJXbSX0jq3MyXlF7RL5yVXiqkJuv3tY2O6W-jwCdxDiJsG2v4IL2LTQGe9Cf7J9D62R9i0Dv-Ff0P43__El63z994NbwiONb4C561vAS9j6rFv8aozbdqufEU7tQkJDsa6j27OTleLi2J5fX65-LUsLJszWfDSEmdsbVltnBMUZqI2hDpha8GUyDGZZLyknLh5RRVxrLJVJQ0HawAIZ_vocHt308W7AVKvG58shGBaiEPSQirOZ-Usg8db0HYxpQ5qvel8tvGoKdEvfnVa6xe_evSbN76Pp4eqAffOj0Iz8GMETLIm1Dm99emdkzwHECJz8y334AM8fvSuXvxZvX7hGY6zmDM</recordid><startdate>200702</startdate><enddate>200702</enddate><creator>Wilson, C</creator><creator>Schulz, S</creator><creator>Waldman, S A</creator><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200702</creationdate><title>Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation</title><author>Wilson, C ; Schulz, S ; Waldman, S A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3738-52c0dacfc3fadd61e46fa01d6cf639608838352150d7b190d3bcbb8a5ecaee053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Drug Approval</topic><topic>Humans</topic><topic>Marketing - methods</topic><topic>Medical sciences</topic><topic>National Institutes of Health (U.S.)</topic><topic>Pharmacology. Drug treatments</topic><topic>Technology, Pharmaceutical - methods</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilson, C</creatorcontrib><creatorcontrib>Schulz, S</creatorcontrib><creatorcontrib>Waldman, S A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilson, C</au><au>Schulz, S</au><au>Waldman, S A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2007-02</date><risdate>2007</risdate><volume>81</volume><issue>2</issue><spage>153</spage><epage>155</epage><pages>153-155</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><coden>CLPTAT</coden><cop>New York, NY</cop><pub>Nature Publishing</pub><pmid>17259939</pmid><doi>10.1038/sj.clpt.6100088</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-9236 |
| ispartof | Clinical pharmacology and therapeutics, 2007-02, Vol.81 (2), p.153-155 |
| issn | 0009-9236 1532-6535 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68955424 |
| source | Wiley-Blackwell Journals; MEDLINE |
| subjects | Biological and medical sciences Biomarkers Drug Approval Humans Marketing - methods Medical sciences National Institutes of Health (U.S.) Pharmacology. Drug treatments Technology, Pharmaceutical - methods United States United States Food and Drug Administration |
| title | Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A11%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomarker%20Development,%20Commercialization,%20and%20Regulation:%20Individualization%20of%20Medicine%20Lost%20in%20Translation&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Wilson,%20C&rft.date=2007-02&rft.volume=81&rft.issue=2&rft.spage=153&rft.epage=155&rft.pages=153-155&rft.issn=0009-9236&rft.eissn=1532-6535&rft.coden=CLPTAT&rft_id=info:doi/10.1038/sj.clpt.6100088&rft_dat=%3Cproquest_cross%3E68955424%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68955424&rft_id=info:pmid/17259939&rfr_iscdi=true |